How Can Clinicians Collaborate to Improve ADHD Medication Adherence?

Thomas E. Brown, PhD, presented about this topic at the 2018 Annual Meeting of The American Professional Society of ADHD and Related Disorders (APSARD) in Washington, DC, in January. Studies show that among both children and adults, there is low adherence to medication treatment for ADHD. Many patients do not take the medications consistently, Brown…

Read More

Recognizing Signs of Conduct Disorder in Young Children With ADHD

Behavior disorders such as oppositional defiant disorder (ODD) and conduct disorder (CD) are diagnosed in about 25 percent of children with ADHD, according to the U.S. Centers for Disease Control and Prevention. Recognizing the signs and starting treatment for conduct disorder early is important as those with CD who haven’t received treatment may be unable…

Read More

No Increased Incidence of ADHD in Amyotrophic Lateral Sclerosis

Patients with amyotrophic lateral sclerosis (ALS) were less likely than the general population to have attention-deficit/hyperactivity disorder (ADHD),1 failing to support the Lulé, Ludolph, and Ludolph hypothesis2 that the 2 diseases share common pathology, according to the results of a study published in Journal of the Neurological Sciences.

Read More

Why people with ADHD can be successful in business

The symptoms of ADHD foster important traits associated with entrepreneurship. That conclusion was reached in a study conducted by an international team of economists, who found that entrepreneurs with ADHD embrace new experiences and demonstrate passion and persistence.

Read More

Reasons People With ADHD Don’t Seek Help

Many people with ADHD go a long, long time without being diagnosed. Sometimes they never get diagnosed. Commonly, this is because they simply don’t know the symptoms of ADHD and no one else recognizes that they have signs of ADHD either, so they live on in not-so-blissful ignorance…Other times, though, people do have an inkling…

Read More

Cost-Effectiveness of Atomoxetine for Treating Children with ADHD

The investigators of a study published in Current Medical Research and Opinion compared annual healthcare costs among children prescribed either atomoxetine or extended-release guanfacine, 2 non-stimulants that have been used to treat attention-deficit/hyperactivity disorder. The findings suggested that patients who initiated atomoxetine monotherapy incurred lower all-cause healthcare costs in a single year by $3086, on…

Read More

ADHD Medications May Reduce The Risk Of Sexually Transmitted Infection

Attention-deficit/hyperactivity disorder (ADHD) increases the risk of subsequent sexually transmitted infections (STIs) among adolescent and young adult populations by about three times, reports a study published in the January 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP). The authors also found that short- and long-term use of ADHD…

Read More

Greater Prevalence of ADHD Found in Adults Seeking Mental Health Services

The prevalence of attention-deficit/hyperactivity disorder (ADHD) identified in an outpatient sample of 492 adults seeking mental health treatment was nearly 10 times higher than the prevalence identified in epidemiological studies, according to a poster presented at the recent 2018 Annual Meeting of The American Professional Society of ADHD and Related Disorders.

Read More

Surprise Stimulus Helps People Stop an Action

Summary: Unexpected sounds make people stop an action more often than when they hear no sounds at all. A new study offers an insight into how sensory cues would speed up the brain’s communication with the motor system.”

Read More

Legal Rights of Students with ADHD

Both parents and educators often struggle to figure out what exactly fits in an educational plan for a child with ADHD. What does the law say, and where does a school’s responsibility end? Where does a student or family’s? I had a chance recently to connect with Matthew Cohen, a national expert on ADHD law.

Read More